mRNA COVID-19 Vaccine
mRNA COVID-19 Vaccine is a biological therapy with 5 clinical trials. Currently 1 active trials ongoing. Historical success rate of 75.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
3
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
75.0%
3 of 4 finished
25.0%
1 ended early
1
trials recruiting
5
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Vaccine Booster (GEO-CM04S1) for the Prevention of COVID-19 in Patients With Chronic Lymphocytic Leukemia
Simultaneous mRNA COVID-19 and IIV Vaccination in Pregnancy Study
Safety of Simultaneous mRNA COVID-19 Vaccine With Other Childhood Vaccines in Young Children
A Open-label Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab
Safety Study About the mRNA Vaccines Against COVID-19 in Children (PEDIVACOV-HCSC)
Clinical Trials (5)
A Vaccine Booster (GEO-CM04S1) for the Prevention of COVID-19 in Patients With Chronic Lymphocytic Leukemia
Simultaneous mRNA COVID-19 and IIV Vaccination in Pregnancy Study
Safety of Simultaneous mRNA COVID-19 Vaccine With Other Childhood Vaccines in Young Children
A Open-label Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab
Safety Study About the mRNA Vaccines Against COVID-19 in Children (PEDIVACOV-HCSC)
All 5 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 5